Peter Tarcha
23Patents
12h-index
28Co-inventors
81Inventor score
Filing activity: Sep 23, 1988 → Apr 5, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5837752A | Semi-interpenetrating polymer networks | Emerging Cross-Sectional Technologies | 246 | Expired |
| US5252459A | Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles | Emerging Cross-Sectional Technologies | 158 | Expired |
| US6890546B2 | Medical devices containing rapamycin analogs | Human Necessities | 153 | Expired |
| US5266498A | Ligand binding assay for an analyte using surface-enhanced scattering (SERS) signal | Emerging Cross-Sectional Technologies | 104 | Expired |
| US5376556A | Surface-enhanced Raman spectroscopy immunoassay | Emerging Cross-Sectional Technologies | 80 | Expired |
| US5567628A | Surface-enhanced raman spectroscopy immunoassay method, composition and kit | Emerging Cross-Sectional Technologies | 58 | Expired |
| US7208190B2 | Method of loading beneficial agent to a prosthesis by fluid-jet application | Physics | 52 | Expired |
| US5445972A | Raman label and its conjugate in a ligand-binding assay for a test sample analyte | Emerging Cross-Sectional Technologies | 29 | Expired |
| US8221495B2 | Integration of therapeutic agent into a bioerodible medical device | Chemistry; Metallurgy | 21 | Active |
| US7399480B2 | Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances using medical devices | Human Necessities | 18 | Expired |
| US10058641B2 | Medical devices containing rapamycin analogs | Human Necessities | 14 | Active |
| US7455853B2 | Medical devices containing rapamycin analogs | Human Necessities | 12 | Expired |
| US7597764B2 | System of loading beneficial agent to a prosthesis by fluid-jet | Physics | 7 | Active |
| US7645476B2 | Method of loading beneficial agent to a prosthesis by fluid-jet application | Physics | 3 | Active |
| US5681754A | Method for improving the performance of an immunoreagent in an immunoassay | Emerging Cross-Sectional Technologies | 3 | Expired |
| US8524148B2 | Method of integrating therapeutic agent into a bioerodible medical device | Emerging Cross-Sectional Technologies | 3 | Active |
| US8569333B2 | Compounds and methods for treatment and prevention of diseases | Human Necessities | 3 | Active |
| US8001926B2 | System and method of loading and detecting beneficial agent on a prosthesis | Physics | 2 | Active |
| US9296011B2 | Prosthesis having varied concentration of beneficial agent | Physics | 0 | Expired |
| US7960405B2 | Compounds and methods for treatment and prevention of diseases | Human Necessities | 0 | Active |
| US8834549B2 | One-step phosphorylcholine-linked polymer coating and drug loading of stent | Emerging Cross-Sectional Technologies | 0 | Active |
| US8153150B2 | Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances for treatment of vascular disorder | Human Necessities | 0 | Active |
| US8084077B2 | One-step phosphorylcholine-linked polymer coating and drug loading of stent | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.